Indofarma Tbk (INAF) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.024x

Based on the latest financial reports, Indofarma Tbk (INAF) has a cash flow conversion efficiency ratio of 0.024x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.71 Billion ≈ $-1.10 Million USD) by net assets (Rp-788.96 Billion ≈ $-46.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INAF cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Indofarma Tbk - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Indofarma Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Indofarma Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indofarma Tbk ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Alisa Pankki Oyj
HE:ALISA
-0.437x
MegaMD Co. Ltd
KQ:133750
-0.005x
Pulsenmore Ltd
TA:PULS
-0.196x
SeaTwirl AB
ST:STW
0.567x
Mistral Iberia Real Estate SOCIMI S.A.
MC:YMIB
-0.026x
SMRT Holdings Bhd
KLSE:0117
0.125x
BoomBit S.A
WAR:BBT
0.089x
Picogram Co. Ltd.
KQ:376180
-0.003x

Annual Cash Flow Conversion Efficiency for Indofarma Tbk (2000–2024)

The table below shows the annual cash flow conversion efficiency of Indofarma Tbk from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Indofarma Tbk.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp-1.14 Trillion
≈ $-67.04 Million
Rp-21.65 Billion
≈ $-1.27 Million
0.019x -91.99%
2023-12-31 Rp-804.15 Billion
≈ $-47.12 Million
Rp-190.10 Billion
≈ $-11.14 Million
0.236x +126.88%
2022-12-31 Rp86.35 Billion
≈ $5.06 Million
Rp-75.95 Billion
≈ $-4.45 Million
-0.880x -581.24%
2021-12-31 Rp508.31 Billion
≈ $29.78 Million
Rp92.90 Billion
≈ $5.44 Million
0.183x +68.96%
2020-12-31 Rp430.33 Billion
≈ $25.22 Million
Rp46.55 Billion
≈ $2.73 Million
0.108x +162.70%
2019-12-31 Rp504.94 Billion
≈ $29.59 Million
Rp20.79 Billion
≈ $1.22 Million
0.041x +129.05%
2018-12-31 Rp496.65 Billion
≈ $29.10 Million
Rp-70.39 Billion
≈ $-4.12 Million
-0.142x -150.69%
2017-12-31 Rp526.41 Billion
≈ $30.85 Million
Rp147.18 Billion
≈ $8.62 Million
0.280x +150.63%
2016-12-31 Rp575.76 Billion
≈ $33.74 Million
Rp-317.96 Billion
≈ $-18.63 Million
-0.552x -343.75%
2015-12-31 Rp592.71 Billion
≈ $34.73 Million
Rp134.28 Billion
≈ $7.87 Million
0.227x -9.82%
2014-12-31 Rp591.96 Billion
≈ $34.69 Million
Rp148.73 Billion
≈ $8.71 Million
0.251x +204.81%
2013-12-31 Rp590.79 Billion
≈ $34.62 Million
Rp-141.62 Billion
≈ $-8.30 Million
-0.240x -280.88%
2012-12-31 Rp650.10 Billion
≈ $38.09 Million
Rp-40.91 Billion
≈ $-2.40 Million
-0.063x -230.42%
2011-12-31 Rp609.19 Billion
≈ $35.70 Million
Rp29.40 Billion
≈ $1.72 Million
0.048x -36.66%
2010-12-31 Rp311.27 Billion
≈ $18.24 Million
Rp23.71 Billion
≈ $1.39 Million
0.076x -43.89%
2009-12-31 Rp298.72 Billion
≈ $17.50 Million
Rp40.56 Billion
≈ $2.38 Million
0.136x +121.50%
2008-12-31 Rp296.60 Billion
≈ $17.38 Million
Rp-187.31 Billion
≈ $-10.98 Million
-0.632x -320.73%
2007-12-31 Rp291.56 Billion
≈ $17.08 Million
Rp83.42 Billion
≈ $4.89 Million
0.286x +9.70%
2006-12-31 Rp280.49 Billion
≈ $16.44 Million
Rp73.15 Billion
≈ $4.29 Million
0.261x +226.07%
2005-12-31 Rp265.25 Billion
≈ $15.54 Million
Rp-54.87 Billion
≈ $-3.22 Million
-0.207x -133.21%
2004-12-31 Rp255.67 Billion
≈ $14.98 Million
Rp159.25 Billion
≈ $9.33 Million
0.623x +310.06%
2003-12-31 Rp267.94 Billion
≈ $15.70 Million
Rp40.70 Billion
≈ $2.39 Million
0.152x +64.33%
2000-12-31 Rp292.57 Billion
≈ $17.14 Million
Rp27.05 Billion
≈ $1.58 Million
0.092x --

About Indofarma Tbk

JK:INAF Indonesia Drug Manufacturers - Specialty & Generic
Market Cap
$22.88 Million
Rp390.51 Billion IDR
Market Cap Rank
#24697 Global
#515 in Indonesia
Share Price
Rp126.00
Change (1 day)
+0.00%
52-Week Range
Rp126.00 - Rp126.00
All Time High
Rp6975.00
About

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutic… Read more